HerbParlor

Urolithin A · Decision hub

Urolithin A Supplements: Compare Labels, Dosage & Value

Urolithin A is a compound produced by gut bacteria from ellagitannins and ellagic acid found in foods such as pomegranates, berries, and walnuts. Not everyone produces it — it depends on the gut microbiome. Urolithin A supplements supply the compound directly, and are marketed heavily around mitochondrial health and aging, but the human evidence is still early. This hub explains what Urolithin A is, how it relates to mitophagy and cellular energy, what the research does and does not yet show, and how to compare real products on declared dose, testing, and standardized value — without treating marketing language as proof.

Start here

What Urolithin A supplements actually are

Urolithin A is a compound produced in the gut when certain bacteria metabolize ellagitannins and ellagic acid — compounds found in foods such as pomegranates, strawberries, raspberries, walnuts, and almonds. It is not, in the first instance, a vitamin or mineral you consume directly; it is a metabolite that some people’s gut microbiome produces from those food compounds. Not everyone produces Urolithin A, and the amount produced varies between individuals depending on the composition of their gut bacteria.

A Urolithin A supplement provides Urolithin A directly, bypassing the gut-bacteria step. This is one reason the supplement form has attracted research and marketing interest: it offers a measured amount of the compound regardless of whether an individual’s microbiome produces it from food. Two Urolithin A products can both say “Urolithin A” and differ in the declared amount per serving, the serving size, the format, the specific material used, and the testing information behind them.

This hub does not recommend a Urolithin A product, dose, or form for any health outcome, including aging or any disease. It explains what the labels mean and how to compare products on declared facts.

Forms & sources

Urolithin A forms & label terminology

These names describe how Urolithin A is presented and how the amount is expressed on a label. The number that matters for comparison is the declared Urolithin A amount per serving, stated consistently in the same unit. This hub does not treat “clinically proven,” “mitochondrial support,” “healthy aging,” or similar marketing language as independent proof of effectiveness, and it does not invent bioavailability, absorption, or purity claims.

Urolithin A
The active ingredient name. On a Supplement Facts panel, “Urolithin A” identifies the compound. Compare the declared amount per serving in milligrams, not the name alone.
Amount per serving
How much Urolithin A a serving delivers, usually stated in milligrams (mg). Common declared amounts on labels include 250 mg, 500 mg, and 1,000 mg per serving, but this hub does not imply that any of these is a recommended or universally best dose. Compare in a single consistent unit so two products are measured the same way.
Serving size & servings per container
A serving may be one capsule, two or more capsules, a softgel, a gummy, or a measured scoop of powder. Serving size and servings per container decide how many doses you are comparing and how long a container lasts — both feed the standardized value. Two products can look similar per serving but differ sharply when one serving is one capsule and the other is two.
Capsules, softgels, gummies & powders
A format choice. Capsules and softgels offer fixed servings; gummies may add sugars or sweeteners; powders may allow flexible dosing but require careful measurement. The format is a convenience and formulation choice, not a quality verdict — compare declared Urolithin A per serving, servings per container, and additional ingredients together. This hub records formats only where documented and does not claim one format is superior.
Branded or standardized materials where documented
Some products name a specific branded or standardized Urolithin A material on the label. Where a named material is documented, that is a label attribute to compare. This hub does not invent proprietary ingredients, does not treat a branded name as proof of superior effectiveness, and records such disclosures only where they actually appear on a label. Importantly, evidence from one proprietary Urolithin A preparation does not automatically apply to every Urolithin A supplement; a named material is a disclosure fact, not a transferable efficacy guarantee.
“Clinically proven,” “mitochondrial support,” “healthy aging”
Marketing terms sometimes used on Urolithin A labels. These are not independently defined or regulated claims, and this hub does not treat them as proof of superior effectiveness, absorption, or health outcomes. Where a product cites a specific study or a named third-party test, that is recorded as an attributed disclosure fact — not silently upgraded into a quality ranking.

Health benefits / health context

Urolithin A and mitochondrial / cellular-energy context

Urolithin A is a gut-microbiota-derived metabolite associated with ellagitannin metabolism: certain gut bacteria convert ellagitannins and ellagic acid found in foods such as pomegranates, berries, and walnuts into Urolithin A. Not everyone produces it, and the amount varies between individuals depending on the gut microbiome.

Its biological rationale centers partly on mitochondrial quality control — in particular mitophagy, the selective breakdown and recycling of damaged mitochondria. Urolithin A has been studied in laboratory and animal models in relation to mitophagy and mitochondrial function, which is the scientific context behind the “mitochondrial health” language used in marketing. Mechanistic plausibility is currently stronger than the human clinical evidence base.

Human supplementation research is still relatively small. The human evidence is strongest around selected muscle and physical-function outcomes and mitochondrial-related biomarkers, but results are not uniformly positive: some earlier trials reported favorable muscle-strength, endurance, or mitochondrial findings, while important primary endpoints have also been neutral, and findings are formulation-, population-, endpoint-, and study-specific.

The 2026 evidence synthesis does not establish broad clinical efficacy. A July 2026 systematic review / meta-analysis of five randomized controlled trials (236 participants) found that quantitative pooling was feasible only for the 6-minute walk test, where the pooled mean difference was approximately +17 m but the 95% confidence interval crossed zero and was not statistically significant (low GRADE certainty); other muscle and biomarker outcomes were heterogeneous and not pooled. This does not establish Urolithin A as effective for physical performance or muscle health.

Long-term outcomes such as longevity, prevention of age-related disease, or disease treatment remain unestablished. This hub does not claim that Urolithin A extends lifespan, reverses or prevents aging, treats sarcopenia, prevents muscle loss, treats cardiovascular, metabolic, or neurodegenerative disease, or guarantees mitochondrial improvement, exercise performance, recovery, or healthy aging. Where such claims reflect search intent, they are explained here as investigated hypotheses rather than established outcomes.

What research says

What research says

Urolithin A has been studied in laboratory, animal, and a growing but still limited number of human studies. The summary below orients you using a five-level evidence hierarchy — (1) mechanism / mitophagy biology, (2) mitochondrial or biochemical biomarkers, (3) physical-function outcomes, (4) clinical outcomes, and (5) long-term health / healthy-aging claims — so that mechanistic plausibility is not confused with demonstrated clinical benefit. It is not a treatment or dosing recommendation, and results vary by population, dose, duration, formulation, and the outcome studied. Mechanistic and animal findings are not established human health benefits.

What the research landscape looks like

  • Mechanism / mitophagy biology

    Much of the interest in Urolithin A comes from laboratory and animal studies examining mitophagy — the selective recycling of damaged mitochondria — and mitochondrial function. These findings are scientific context and are hypothesis-generating; they are not established human health benefits. This hub does not present laboratory, animal, mechanistic, or observational findings as proof of an effect in people. Mechanistic plausibility is currently stronger than the human clinical evidence base.

  • July 2026 systematic review / meta-analysis of muscle health outcomes

    A July 2026 systematic review and meta-analysis (Dao et al., Frontiers in Nutrition, 2026;13:1834344; PMID 42559151; DOI 10.3389/fnut.2026.1834344) pooled human randomized controlled trials of Urolithin A supplementation on muscle health outcomes. Five randomized controlled trials were included, with a total sample size of 236 participants. The trials were small and short-term and involved clinically heterogeneous populations. Quantitative pooling was feasible only for the 6-minute walk test, based on two trials; the pooled mean difference was approximately +17 m, but the 95% confidence interval crossed zero and the result was not statistically significant, with GRADE certainty rated low for that outcome. Muscle strength, endurance, aerobic capacity, and biochemical or mitochondrial biomarkers were heterogeneous across trials and were not quantitatively pooled; those non-6MWT findings should be read as exploratory and hypothesis-generating rather than as reproducible evidence of efficacy. The review concluded that larger, longer, and better-standardized trials are needed. This synthesis does not establish Urolithin A as proven to improve physical performance, muscle health, healthy aging, or longevity.

  • Earlier randomized human evidence, kept in context

    A 2022 randomized trial of a specific Urolithin A preparation reported favorable findings for muscle strength and aerobic endurance in its study population, while its primary peak-power endpoint was neutral. That trial used a particular Urolithin A formulation, dose, duration, and population; its results are formulation- and study-specific and do not automatically apply to every Urolithin A supplement. This hub retains the finding as useful context but does not generalize one sponsored or formulation-specific study to all Urolithin A products, and does not treat favorable secondary endpoints as proof that the neutral primary endpoint was overcome.

  • Mitochondrial and biochemical biomarkers vs clinical outcomes

    Some earlier human trials reported changes in markers related to mitochondrial function or muscle in certain groups. A change in a biomarker or a cellular process is not the same as a demonstrated patient-important clinical outcome. Biomarker findings sit at level 2 of the evidence hierarchy above; they are not, on their own, evidence that a supplement treats, prevents, or cures any condition, and they do not guarantee improved physical performance, recovery, or healthy aging.

  • 2026 translational context

    A 2026 translational review (Frontiers in Nutrition, August 2026) frames urolithins as gut-microbial metabolites moving toward precision interventions. It makes clear that mechanistic plausibility is stronger than the current clinical evidence base; that some earlier human trials reported favorable muscle-strength, endurance, or mitochondrial findings; that important primary endpoints have also been neutral; and that evidence remains formulation-, population-, endpoint-, and study-specific. This hub does not turn mechanistic mitophagy findings into claims of guaranteed muscle preservation, longevity, anti-aging effects, or disease prevention.

  • Variability in natural production

    Because Urolithin A is produced by gut bacteria from ellagitannins and ellagic acid, not everyone produces it from food, and the amount varies between individuals. This is one reason a direct supplement form is studied, but it does not by itself establish that supplementation produces a specific health benefit.

  • “Anti-aging” and “longevity” as concepts, not outcomes

    “Anti-aging,” “longevity,” and “muscle rejuvenation” are research and marketing concepts, not established, measurable health outcomes. This hub does not claim that Urolithin A prevents, reverses, or treats aging or muscle loss, and does not present these terms as proven benefits. Where they appear, they are identified as concepts under study, not results. Long-term outcomes such as lifespan extension, prevention of age-related disease, or disease treatment remain unestablished by current randomized human evidence.

Intake & dosage reference

Intake & dosage reference

There is no government-established recommended daily intake or dietary reference value for Urolithin A, and no authoritative body has established a recommended dose for any health outcome. The amounts below describe what appears on labels and in research, not a personal recommendation. This is general reference information for understanding labels, not individualized advice.

GroupReference value
Dietary reference valueNo established RDA, AI, or daily reference value for Urolithin A
Tolerable upper intake levelNo established UL for Urolithin A
Amounts commonly declared on labelsTypically 250 mg to 1,000 mg per serving; varies by product
Amounts used in researchVaries by study, population, and outcome; not generalizable to a recommended dose

These are not personal dosing instructions. Because there is no authoritative recommended dose for Urolithin A, any amount you see on a label or in a study is a declared or studied amount — not a recommendation. Dosing for any clinical purpose, especially for people who take medications, are pregnant or nursing, or have a medical condition, is a decision for a healthcare professional.

Safety & side effects

Safety & side effects

Human safety data for Urolithin A is still limited compared with long-studied nutrients. In the small, short-term human studies published so far, Urolithin A has generally been reported to be well tolerated at the amounts studied, but the evidence base is not large enough to establish a full safety profile. This is general orientation, not an exhaustive assessment.

Anyone who takes medications, is pregnant or nursing, or has a medical condition should discuss use with a healthcare professional before starting. Because Urolithin A is a compound involved in cellular processes, its interactions and long-term effects are still being studied.

  • Limited long-term human safety data

    Most published human studies of Urolithin A are small and short-term. Longer-term safety in humans, including at higher amounts and with sustained use, has not been established. Treat any high-amount or long-term regimen as a decision to discuss with a healthcare professional rather than a settled practice.

  • Reported effects in studies

    Where human studies report effects, they have generally been mild. As with any supplement, individual responses can vary. If you experience persistent or worsening effects, stop use and discuss with a healthcare professional.

  • Pregnancy, nursing, and medical conditions

    Whether a Urolithin A supplement is appropriate in pregnancy, while nursing, or alongside any medical condition or medication is a decision for a healthcare professional. This hub does not recommend Urolithin A for any specific situation or outcome.

  • Combination with other supplements

    Urolithin A is sometimes combined with other compounds marketed around mitochondrial health or aging. Total intake and combination effects are not well characterized in humans. Review everything you take together and discuss combination use with a healthcare professional if you take medication or have a medical condition.

Interactions & important considerations

Interactions & important considerations

Because Urolithin A is involved in cellular processes such as mitophagy and mitochondrial function, there are plausible interactions with medications or conditions that affect those pathways, but the human interaction evidence is limited. This is general orientation, not an exhaustive list — check with a pharmacist or doctor about your own medications and health situation.

Medications affecting cellular or metabolic pathways
Urolithin A has been studied in relation to mitochondrial and cellular processes. Medications or conditions that affect these pathways could in principle interact with Urolithin A, but specific human interaction data is limited. Discuss Urolithin A use with the clinician managing any such medication before starting.
Muscle, metabolic, and cardiovascular medications
Some early research has examined Urolithin A in relation to muscle and metabolic markers, but the human evidence is limited and no interaction is established. If you take medications for metabolic, cardiovascular, or muscle-related conditions, discuss any Urolithin A use with the clinician managing that therapy before starting.
Combination products and other supplements
Products that combine Urolithin A with other compounds marketed around mitochondrial health or aging — such as NAD+ precursors like NMN, resveratrol, or antioxidants — carry the considerations of those added ingredients, which are separate from Urolithin A alone. Review the full ingredient list and discuss combination use with a healthcare professional if you take medication or have a medical condition.
Gut-microbiome considerations
Because Urolithin A is normally produced by gut bacteria from ellagitannins and ellagic acid, factors that affect the gut microbiome may influence natural production. This is biological context, not an interaction warning, and no specific microbiome-based dosing rule is established. Discuss any concerns with a healthcare professional.

Sources

Sources

The context and terminology above are drawn from publicly available authoritative and scientific sources. HerbParlor does not independently verify the contents of third-party sites, and does not endorse any specific study’s conclusions as established health advice.

Decision criteria

Which Urolithin A should you compare?

No single Urolithin A product is “best” for everyone, and no Urolithin A product is established as effective for any health outcome. These neutral criteria help you narrow the field to the products worth comparing side by side. They use only the facts HerbParlor already structures and scores — nothing here is influenced by affiliate availability, commission, merchant, or a sponsored ranking.

Urolithin A amount per serving
How much Urolithin A a serving delivers, usually stated in milligrams (mg). Compare the declared amount in a single consistent unit. Note any product that lists Urolithin A only inside a proprietary blend, where the individual amount is not visible. A higher declared amount is not automatically better and is not a recommendation.
Serving size
A serving may be one capsule, several capsules, a softgel, a gummy, or a scoop of powder. Serving size and servings per container decide how many doses you are comparing and how long a container lasts — both feed the standardized value. Two products can look similar per serving but differ sharply when one serving is one capsule and the other is two.
Formulation / format
Whether the product is a capsule, softgel, gummy, or powder, and whether it contains only Urolithin A or adds other compounds. The format is a convenience and formulation choice, not a quality verdict. A combination product is a different formulation, not a stronger version of the same Urolithin A. Compare the declared amount and the full ingredient list together.
Ingredient identity & standardized/branded material where documented
Whether the label names “Urolithin A” clearly, and whether it names a specific branded or standardized material. Where a named material is documented, that is an attributed disclosure fact to compare. This hub does not invent proprietary ingredients and does not treat a branded name as proof of superior effectiveness. If a product cites a specific clinical study, check whether the studied formulation and the product being compared are actually equivalent — evidence from one proprietary Urolithin A preparation does not automatically apply to every Urolithin A supplement.
Additional ingredients
A clear ingredient list, named excipients, capsule or softgel or gummy material, and any added compounds are part of HerbParlor’s transparency scoring. More added ingredients are not automatically better. A combination product carries the considerations of its added ingredients, separate from Urolithin A alone.
Manufacturer & source transparency
A named manufacturer, a stated country of origin, and traceable sourcing are part of HerbParlor’s transparency scoring. Products that disclose more are easier to compare; products that disclose less are reported as such, not ranked against them.
Documented testing & verification
Look for reported third-party testing, a named lab, or certifications — and note whether that is independent verification or a brand/retailer claim. HerbParlor records testing information as attributed and never upgrades a claim to independent verification.
Price per serving & value (VitaValue™)
VitaValue™ puts price next to a comparable quantity — cost per serving — so capsule count, serving size, and packaging cannot disguise the real cost. Use it to compare value only after the criteria above are acceptable to you.
Enough information to compare?
A meaningful comparison needs the declared Urolithin A amount, the serving size, the ingredient list, and at least some documented testing or sourcing. If a product leaves these blank or hides Urolithin A in a proprietary blend, it cannot be fairly compared yet — that is a fact about disclosure, not a judgment of the product itself.

Compare

How to read a Urolithin A label

Use the same criteria for every product. These are the facts HerbParlor structures and scores on — and the ones worth checking yourself before you decide. The facts that matter most are the declared Urolithin A amount per serving and the serving size; none alone tells you what you get, and marketing language is never a substitute for declared facts.

  1. 01

    Urolithin A amount per serving

    How much Urolithin A a serving delivers, usually stated in milligrams (mg). Compare in a single consistent unit so two products are measured the same way. Note any product that lists Urolithin A only inside a proprietary blend, where the individual amount is not visible.

  2. 02

    Serving size & servings per container

    A serving may be one capsule, several capsules, a softgel, a gummy, or a scoop of powder. Serving size and servings per container decide how many doses you are comparing and how long a container lasts — both feed the standardized value.

  3. 03

    Ingredient identity & formulation

    Whether the label names “Urolithin A” clearly, and whether the product contains only Urolithin A or adds other compounds (such as NAD+ precursors, resveratrol, or fillers). A combination product is a different formulation, not a stronger version of the same Urolithin A. Compare the declared Urolithin A amount and the full ingredient list together.

  4. 04

    Branded or standardized material where documented

    Where a product names a specific branded or standardized Urolithin A material, that is an attributed disclosure fact to compare. This hub does not invent proprietary ingredients and does not treat a branded name as proof of superior effectiveness. If a product makes a claim based on a specific clinical study, check whether the studied formulation and the product being compared are actually equivalent — evidence from one proprietary Urolithin A preparation does not automatically apply to every Urolithin A supplement.

  5. 05

    Marketing language is not proof

    Terms like “clinically proven,” “mitochondrial support,” “healthy aging,” or “longevity” are not independently defined or regulated claims. This hub does not treat them as proof of superior effectiveness or health outcomes. Where a product cites a specific study or named test, that is recorded as an attributed disclosure fact.

  6. 06

    Additional ingredients & formulation transparency

    A clear ingredient list, named excipients, capsule or softgel or gummy material, and any added compounds are part of HerbParlor’s transparency scoring. More added ingredients are not automatically better. Missing or vague disclosure is reported as unavailable, not silently treated as a failure or a pass.

  7. 07

    Testing & certifications

    Whether the product reports third-party testing, a named lab, or certifications — and whether that is independent verification or a brand/retailer claim. These are recorded as attributed, never silently upgraded.

  8. 08

    Standardized value

    VitaValue™ puts price next to a comparable quantity — cost per serving — so capsule count, serving size, and packaging don’t disguise the real cost. Use it to compare value only after the criteria above are acceptable to you.

Tools

Decision tools to help you choose

These are HerbParlor’s existing tools, contextualised for urolithin a. Each one turns research into a shortlist you can act on — no sponsored rankings, no hidden ordering.

Find My Supplement

Start from your goal — not a product page — and get an evidence-aligned, scored shortlist.

Try the matcher

Analyze a Label

Enter supplement label information and get a structured, neutral ingredient-by-ingredient analysis.

Analyze a label

Compare Products

Place products side by side and see where each one earns — or loses — its score.

Open comparison

Value Calculator

See standardized cost per comparable unit so price sits next to what you actually get.

Calculate value

Testing Checker

See what testing and certification information HerbParlor has recorded for a product.

Check testing info

Transparency Checker

Review how much of a product’s profile is disclosed and documented across our eight dimensions.

Check transparency

Compare products

Urolithin A supplements in HerbParlor

Every product below is a real, canonical record assessed with the same VitaScore™ rubric. Open any product for the full profile, or compare several side by side.

More urolithin a products will appear here as verified data is added.

Browse the full supplement explorer in the meantime.

Trust & methodology

How HerbParlor evaluates Urolithin A products

Every Urolithin A product in this hub is assessed with the same transparent VitaScore™ rubric — eight dimensions covering label transparency, dose transparency, ingredient/form specificity, quality verification, source provenance, product/manufacturer transparency, evidence linkage, and standardized value. The rubric is the same for every product and every category.

VitaScore™ is a transparency and documentation score. It is not a measure of medical effectiveness, safety, or suitability for an individual. A product with more disclosed, documented information scores higher; missing information is reported as unavailable, never silently treated as a failure.

  1. 01

    No sponsored rankings. Ever.

    HerbParlor sells nothing and takes no placement fees. Scores cannot be bought, influenced, or negotiated.

  2. 02

    Testing information over label claims

    We note when products report third-party testing, and say so when a product reports none. A manufacturer or retailer claim is never treated as independent verification.

  3. 03

    Affiliate-neutral

    Commercial relationships do not influence scores, ordering, or what appears on this hub. Retailer links appear only when verified and are kept separate from editorial analysis.

FAQ

Common questions, answered plainly

What does the latest research say about Urolithin A?
A July 2026 systematic review and meta-analysis (Dao et al., Frontiers in Nutrition, 2026;13:1834344; PMID 42559151) pooled five randomized controlled trials of Urolithin A supplementation on muscle health outcomes, with 236 participants total. The trials were small, short-term, and clinically heterogeneous. Quantitative pooling was feasible only for the 6-minute walk test (two trials): the pooled mean difference was approximately +17 m, but the 95% confidence interval crossed zero and was not statistically significant, with low GRADE certainty. Muscle strength, endurance, aerobic capacity, and biochemical or mitochondrial biomarkers were heterogeneous and were not quantitatively pooled, so those findings are exploratory and hypothesis-generating rather than reproducible evidence of efficacy. The review concluded that larger, longer, and better-standardized trials are needed. Current evidence does not establish Urolithin A as effective for physical performance, muscle health, healthy aging, or longevity.
Does Urolithin A improve muscle strength or physical performance?
This is not established. The 2026 systematic review found that the only outcome that could be quantitatively pooled — the 6-minute walk test — showed a pooled mean difference of approximately +17 m that was not statistically significant (the 95% confidence interval crossed zero), with low GRADE certainty. Muscle strength, endurance, and aerobic capacity outcomes were heterogeneous across trials and were not pooled, so any favorable findings in individual trials should be read as exploratory and hypothesis-generating. A 2022 randomized trial of a specific Urolithin A preparation reported favorable muscle-strength and aerobic-endurance findings while its primary peak-power endpoint was neutral; that result is formulation- and study-specific and does not automatically apply to every Urolithin A supplement. Evidence remains low-certainty and limited.
Does Urolithin A improve mitochondrial function?
Some earlier human trials reported changes in markers related to mitochondrial function in certain groups, but a change in a biomarker or cellular process is not the same as a demonstrated patient-important clinical outcome. Biomarker findings are hypothesis-generating and do not guarantee improved physical performance, recovery, or healthy aging. The 2026 systematic review found that biochemical and mitochondrial biomarkers were heterogeneous across trials and were not quantitatively pooled. This hub does not claim that Urolithin A guarantees mitochondrial improvement.
What is mitophagy and why is Urolithin A studied for it?
Mitophagy is the process by which cells selectively break down and recycle damaged mitochondria, as part of mitochondrial quality control. Urolithin A has been studied in laboratory and animal models in relation to mitophagy and mitochondrial function, which is the scientific context behind “mitochondrial health” marketing language. This is mechanistic plausibility, not proof of a specific health outcome — and mechanistic plausibility is currently stronger than the human clinical evidence base. This hub does not claim that stimulating mitophagy through Urolithin A treats, prevents, or cures any condition.
Is Urolithin A proven to slow aging or extend lifespan?
No. “Anti-aging,” “longevity,” and “muscle rejuvenation” are research and marketing concepts, not established health outcomes. This hub does not claim that Urolithin A extends lifespan, reverses or prevents aging, treats sarcopenia, prevents muscle loss, or guarantees healthy aging. Some laboratory and animal studies examine mitophagy and mitochondrial function, and some small human studies report changes in related markers, but a change in a biomarker or cellular process is not the same as a demonstrated health outcome. Long-term outcomes such as lifespan extension, prevention of age-related disease, or disease treatment remain unestablished by current randomized human evidence.
What should I compare when choosing a Urolithin A supplement?
Compare the declared Urolithin A amount per serving (in a single consistent unit), the serving size and servings per container, the formulation identity (whether the product contains only Urolithin A or adds other compounds), any branded or standardized material named on the label, the full ingredient list, and the testing and transparency information. If a product makes a claim based on a specific clinical study, check whether the studied formulation and the product being compared are actually equivalent — evidence from one proprietary Urolithin A preparation does not automatically apply to every Urolithin A supplement. A higher declared amount is not automatically better and is not a recommendation. Use the existing HerbParlor tools — the comparison tool, Analyze a Label, Testing Checker, Supplement Value Calculator, Evidence Checker, and Dose Analyzer — to line up real products on these facts.
Where does Urolithin A come from?
Urolithin A is a gut-microbiota-derived metabolite produced by certain gut bacteria from ellagitannins and ellagic acid — compounds found in foods such as pomegranates, berries, and walnuts. Not everyone produces it, and the amount varies between individuals depending on the gut microbiome. A Urolithin A supplement provides the compound directly, bypassing the gut-bacteria step.
What is the recommended Urolithin A dosage?
There is no authoritative recommended dose for Urolithin A. No government body has established a dietary reference value or tolerable upper intake level for Urolithin A. Amounts commonly declared on labels range from around 250 mg to 1,000 mg per serving, and amounts used in research vary by study. Any amount on a label or in a study is a declared or studied amount, not a recommendation. Dosing for any clinical purpose is a decision for a healthcare professional.
Is a 500 mg Urolithin A serving better than 250 mg?
This hub does not imply that any declared amount — 250 mg, 500 mg, 1,000 mg, or another — is universally best. There is no authoritative recommended dose for Urolithin A. Compare the declared amount per serving in a single consistent unit, alongside the serving size, the ingredient list, and the testing information. A higher declared amount is not automatically better and is not a recommendation.
Are Urolithin A’s benefits proven in humans?
Not yet for any specific health outcome. The 2026 systematic review of five randomized controlled trials (236 participants) found that the only pooled outcome — the 6-minute walk test — was not statistically significant (low GRADE certainty), and other muscle and biomarker outcomes were heterogeneous and not pooled. Some small, short-term human studies report changes in markers related to mitochondrial function or muscle in certain groups, but the body of human clinical evidence remains limited in size, duration, and outcomes measured. Laboratory, animal, mechanistic, and observational findings are hypothesis-generating and are not established human health benefits. This is a developing research area.
Is “clinically proven” or “mitochondrial support” a guarantee?
No. Terms like “clinically proven,” “mitochondrial support,” and “healthy aging” are marketing language, not independently defined or regulated claims. This hub does not treat them as proof of superior effectiveness or health outcomes. Where a product cites a specific study or a named third-party test, that is recorded as an attributed disclosure fact — not silently upgraded into a quality ranking. If a product cites a specific clinical study, check whether the studied formulation and the product being compared are actually equivalent.
Can Urolithin A interact with my medications?
Specific human interaction data for Urolithin A is limited. Because Urolithin A is studied in relation to mitochondrial and cellular processes, there are plausible interactions with medications or conditions that affect those pathways, but no interaction is established. Discuss any Urolithin A use with the clinician or pharmacist managing your medications before starting.

This hub is provided for educational purposes only and is not medical advice. It does not claim that any urolithin a form, source, or product is better for any health outcome. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, nursing, taking medication, or subject to anti-doping rules.